|

INV-6452 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shenzhen Ionova Life Sciences Co., Ltd.1

Indications

  • Metastatic (Stage IV) Breast Cancer1
  • Breast Cancer (Locally Advanced or Metastatic)1
  • Advanced Solid Cancers1
  • Endometrial Cancer1
  • Ovarian Cancer1

Other1 trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.